Sort
15,842 grants matching “pancreatic cancer”
The Role of Ire1 in Modulating the Response of Tumors to Hypoxia and Radiation
$204,282Albert Koong · Stanford University · P01 · FY2016 · CA
The Role of Ire1 in Modulating the Response of Tumors to Hypoxia and Radiation
$204,282Albert Koong · Stanford University · P01 · FY2017 · CA
Ameliorating lymphocyte depletion and functional impairment following lung SBRT
$204,253Krishni Wijesooriya · University Of Virginia · R01 · FY2020 · CA
Project 2
$204,240Wilfred Ngwa · Johns Hopkins University · U54 · FY2024 · CA
Application of Mucolytic Therapy in Patient-Derived Models of Pseudomyxoma Peritonei
$204,233Mohammad Haroon Asif Choudry · University Of Pittsburgh At Pittsburgh · R21 · FY2020 · CA
Mouse model to study dependence of pancreatic cancer on Pik3ca for progression
$204,076Richard Z Lin · State University New York Stony Brook · R21 · FY2016 · CA
MDSC-Tumor Crosstalk in Prostate Cancer Progression and Castration Resistance
$204,038Guocan Wang · University Of Tx Md Anderson Can Ctr · R00 · FY2018 · CA
HYDROLYSIS OF VITAMIN A ESTERS IN LIVER
$204,034U.S. Department Of Agriculture · R01 · FY2000 · DK
Divalent cation activation of the integrin-mediated malignant phenotype in pancre
$203,940Michael Bouvet · University Of California, San Diego · R21 · FY2009 · CA
The Role of N-cadherin in Tumor Progresion
$203,940Glenn Lawrence Radice · Thomas Jefferson University · R21 · FY2010 · CA
Variations of calorie restriction for the prevention of pancreatic cancer
$203,940Susan Lanza-Jacoby · Thomas Jefferson University · R21 · FY2009 · CA
Sensitized screen to identify cooperating genes involved in pancreatic cancer
$203,940Arthur M. Buchberg · Thomas Jefferson University · R21 · FY2009 · CA
Identifying insulin resistance biomarkers and metabolomic signature as predictors of precursors to pancreatic cancer
$203,906Jianjun Zhang · Indiana University Indianapolis · R21 · FY2016 · CA
Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation
$203,904Benjamin Tycko · Columbia University Health Sciences · U54 · FY2011 · CA
Studies of Attenuated Salmonella with IL-2 against pancreatic cancer
$203,850Daniel Alan Saltzman · University Of Minnesota · R21 · FY2008 · CA
The Role of MUC1 in the Pathogenesis of Pancreatic Cancer
$203,850Ashok K Saluja · University Of Minnesota · R21 · FY2008 · CA
Exploratory Trial of Curcumin in Pancreatic Cancer
$203,850University Of Texas Md Anderson Can Ctr · R21 · FY2005 · CA
Integrin Contributions to Pancreatic Cancer
$203,850Kathleen L O'Connor · University Of Texas Med Br Galveston · R21 · FY2008 · CA
Exploratory Trial of Curcumin in Pancreatic Cancer
$203,850University Of Texas Md Anderson Can Ctr · R21 · FY2004 · CA
Hedgehog signaling in pancreatic neoplasia
$203,802Johns Hopkins University · R21 · FY2005 · DK
ENDOGENOUS OPIOID MODULATION OF HUMAN PANCREATIC CANCER
$203,784Pennsylvania State Univ Hershey Med Ctr · R01 · FY2000 · CA
NUR77 Agonists: New Targets for Pancreatic Cancer Chemotherapy
$203,700Stephen H Safe · Texas A&M University Health Science Ctr · R01 · FY2007 · CA
NUR77 Agonists: New Targets for Pancreatic Cancer Chemotherapy
$203,700Stephen H Safe · Texas A&M University Health Science Ctr · R01 · FY2008 · CA
Familial Markers of Risk
$203,693Alison P Klein · Johns Hopkins University · P50 · FY2012 · CA
P-2: Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers
$203,625Suresh T. Chari · Mayo Clinic Rochester · P50 · FY2008 · CA